Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107672613 | 10767261 | 3 | F | 2012 | 20160913 | 20150205 | 20160920 | EXP | BR-DSJP-DSJ-2015-103266 | DAIICHI | 0.00 | Y | 0.00000 | 20160920 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107672613 | 10767261 | 1 | PS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | |||||
| 107672613 | 10767261 | 2 | SS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, BID | U | 21286 | 40 | MG | TABLET | BID | |||||
| 107672613 | 10767261 | 3 | SS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | |||||
| 107672613 | 10767261 | 4 | SS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, BID | U | 21286 | 40 | MG | TABLET | BID | |||||
| 107672613 | 10767261 | 5 | SS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | U | 21286 | 40 | MG | TABLET | QD | |||||
| 107672613 | 10767261 | 6 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500MG/DAY | 0 | FILM-COATED TABLET | |||||||||
| 107672613 | 10767261 | 7 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 107672613 | 10767261 | 8 | C | WARFARINE | WARFARIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107672613 | 10767261 | 1 | Hypertension |
| 107672613 | 10767261 | 6 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107672613 | 10767261 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107672613 | 10767261 | Appendicitis | |
| 107672613 | 10767261 | Diabetes mellitus | |
| 107672613 | 10767261 | Hypertension | |
| 107672613 | 10767261 | Intentional product misuse | |
| 107672613 | 10767261 | Urinary tract infection bacterial |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107672613 | 10767261 | 1 | 2010 | 0 | ||
| 107672613 | 10767261 | 3 | 20150128 | 0 | ||
| 107672613 | 10767261 | 4 | 20150129 | 20150129 | 0 | |
| 107672613 | 10767261 | 5 | 20150130 | 0 | ||
| 107672613 | 10767261 | 6 | 2012 | 0 |